Treatment Outcomes and Prognostic Factors in Patients with Multidrug-Resistant Tuberculosis in Korean Private Hospitals
![]() ![]() |
Park, Jin-Kyeong
(Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine)
Koh, Won-Jung (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Kim, Deog-Kyeom (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Kim, Eun-Kyung (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Kim, Yu-Il (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Kim, Hee-Jin (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Kim, Tae-Hyung (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Kim, Jae-Yeol (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Park, Moo-Suk (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Park, I-Nae (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Park, Jae-Seuk (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Lee, Ki-Man (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Song, Sook-Hee (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Lee, Jin-Hwa (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Lee, Seung-Heon (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Lee, Hyuk-Pyo (Korean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Yim, Jae-Joon (2KoreanKorean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Lim, Jae-Min (2KoreanKorean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) JeGal, Yang-Jin (2KoreanKorean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Jung, Ki-Hwan (2KoreanKorean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Huh, Jin-Won (2KoreanKorean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Choi, Jae-Chol (2KoreanKorean TB Study Group, Korean Academy of Tuberculosis and Respiratory Diseases) Shim, Tae-Sun (Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine) |
1 | Park SK, Lee CM, Heu JP, Song SD. A retrospective study for the outcome of pulmonary resection in 49 patients with multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2002;6:143-149. |
2 | Kim DH, Kim HJ, Park SK, Kong SJ, Kim YS, Kim TH, et al. Treatment outcomes and long-term survival in patients with extensively drug-resistant tuberculosis. Am J Respir Crit Care Med 2008;178:1075-1082. DOI ScienceOn |
3 | World Health Organization. Extensively drug-resistant tuberculosis (XDR-TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006;81:430-432. |
4 | Laserson KF, Thorpe LE, Leimane V, Weyer K, Mitnick CD, Riekstina V, et al. Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2005;9:640-645. |
5 | Migliori GB, Sotgiu G, D'Arcy Richardson M, Centis R, Facchini A, Guenther G, et al. MDR-TB and XDR-TB: drug resistance and treatment outcomes. Eur Respir J 2009;34:778-779. DOI ScienceOn |
6 | Korea Center for Disease Control and Prevention, Korean Institute of Tuberculosis. Annual report on the notified tuberculosis patients in Korea. Seoul: Korea Center for Disease Control and Prevention; 2005. |
7 | Koh WJ, Kwon OJ, Kim CH, Ahn YM, Lim SY, Yun JW, et al. Clinical characteristics and treatment outcomes of patients with pulmonary tuberculosis at a private general hospital. Tuberc Respir Dis 2003;55:154-164. |
8 | Caminero JA; World Health Organization; American Thoracic Society; British Thoracic Society. Treatment of multidrug-resistant tuberculosis: evidence and controversies. Int J Tuberc Lung Dis 2006;10:829-837. |
9 | Jeon D, Shin D, Kang H, Sung N, Kweon K, Shin E, et al. Trend of multidrug and extensively drug resistant tuberculosis in a tuberculosis referral hospital, 2001- 2005. Tuberc Respir Dis 2008;64:187-193. DOI ScienceOn |
10 | World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. Geneva: World Health Organization; 2008. |
11 | Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, et al. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis. Clin Infect Dis 2008;47:496-502. DOI ScienceOn |
12 | Rivers EC, Mancera RL. New anti-tuberculosis drugs with novel mechanisms of action. Curr Med Chem 2008;15:1956-1967. DOI ScienceOn |
13 | Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page-Shipp L, et al. The diarylquinoline TMC 207 for multidrug-resistant tuberculosis. N Engl J Med 2009;360:2397-2405. DOI ScienceOn |
14 | Koh WJ, Kwon OJ, Gwak H, Chung JW, Cho SN, Kim WS, et al. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drug-resistant tuberculosis. J Antimicrob Chemother 2009;64:388-391. DOI ScienceOn |
15 | Park IN, Hong SB, Oh YM, Kim MN, Lim CM, Lee SD, et al. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. J Antimicrob Chemother 2006;58:701-704. DOI ScienceOn |
16 | Shiraishi Y, Nakajima Y, Katsuragi N, Kurai M, Takahashi N. Resectional surgery combined with chemotherapy remains the treatment of choice for multidrugresistant tuberculosis. J Thorac Cardiovasc Surg 2004; 128:523-528. DOI |
17 | Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, et al. Impact of extensive drug resistance on treatment treatment outcomes in non-HIV-infected patients with multidrug- resistant tuberculosis. Clin Infect Dis 2007;45: 1290-1295. DOI ScienceOn |
![]() |